1. Previous studies on the thermoregulatory effects of alpha-adrenocep
tor antagonists have been performed primarily in animals and the findi
ngs have been inconsistent, There is evidence for thermoregulatory imp
airment by alpha-adrenergic antagonists in humans not exposed to cold,
but the effects of alpha-adrenergic blockade during cold challenge ha
ve not been investigated. 2. Fourteen healthy human volunteers (seven
elderly, aged 55-68 years and seven young, aged 19-27 years) were stud
ied on three separate days and received three randomly assigned treatm
ents: (i) control (no drug), (ii) low-dose phentolamine, and (iii) hig
h-dose phentolamine, On each day cold intravenous saline (4 degrees C)
was given until both vasoconstriction and shivering were triggered or
a maximum fluid volume (40 ml/kg) was delivered, Core temperature, pe
ripheral vasoconstriction and metabolic heat production were measured.
3. The alpha-adrenoceptor antagonist caused a dose-dependent inhibiti
on of vasoconstriction in the elderly but did not impair vasoconstrict
ion in the young subjects at the doses that were given, Shivering and
metabolic heat production were unaffected by alpha-adrenergic blockade
in the elderly or in the young. 4. These findings illustrate the sele
ctive inhibition of vasoconstriction (but not shivering) by alpha-adre
noceptor antagonism in elderly individuals. Compared with the young, t
he elderly are more sensitive to the effects of ct-antagonists, perhap
s due to downregulation of the alpha-adrenoceptor. These findings lead
us to conclude that thermoregulatory vasoconstriction is alpha-adrene
rgically mediated, and this response is attenuated by alpha-adrenocept
or blockade in elderly humans.